Author name: suadm

Rising Tide Foundation for Clinical Cancer Research – CALL for REVIEWERS September 20, 2022 For our upcoming Grant Review Committee, we are looking for reviewers for clinical cancer research proposals.   We are searching for the following medical expertise:   Advanced gastrointestinal cancer management  Pancreatic surgery and pancreatic cancer management  Platinum-sensitive, recurrent epithelial ovarian cancer  In addition, we are looking …

Rising Tide Foundation for Clinical Cancer Research – CALL for REVIEWERS Read More »

Welcome to Annie Ellis our new Patient Advisory Board Member September 2, 2022 This week we welcome a new Patient Advisory Board Member – Annie Ellis. As a cancer survivor, she brings invaluable experience and knowledge, and we are excited to work with her to improve patient involvement in cancer research. Annie Ellis contributes patient …

Welcome to Annie Ellis our new Patient Advisory Board Member Read More »

Rondine visits Rising Tide September 1, 2022 A presentation of the Rondine project to the Rising Tide Foundation and Rising Tide Foundation for Clinical Cancer Research Board of Directors. Last week we had the pleasure of welcoming the Managing Director of Rondine Cittadella della Pace, Stefano Isacchi, and a second-year Bosnian student of their World …

Rondine visits Rising Tide Read More »

A New Era in Patient-Centered Research: Supporting patient-directed clinical trials through the geriatric oncology therapy optimization (GOTO) program August 30, 2022 With the support of Rising Tide Foundation for Clinical Cancer Research (RTFCCR), City of Hope, one of the largest cancer research and treatment organizations in the United States, will launch five coordinated, high-quality research …

A New Era in Patient-Centered Research: Supporting patient-directed clinical trials through the geriatric oncology therapy optimization (GOTO) program Read More »

TRIAL UPDATE: First patient enrolled EORTC TOLERANCE July 28, 2022 TRIAL UPDATE: First patient was enrolled in the EORTC TOLERANCE academic clinical trial in elderly patients with advanced soft tissue sarcoma. TOLERANCE is an international study with 9 participating countries. We are proud to support our partner EORTC and would like to say thank you for the good collaboration. You can …

TRIAL UPDATE: First patient enrolled EORTC TOLERANCE Read More »